NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

Tauopathies治療市場 - COVID-19的影響分析,市場規模、佔有率、預測:2021年∼2027年

Tauopathies Treatment Market with COVID-19 Impact Analysis, By Disease, By Distribution Channel, and By Region - Size, Share, & Forecast from 2021-2027

出版商 AnalystView Market Insights 商品編碼 980684
出版日期 內容資訊 英文 210 Pages
商品交期: 2-3個工作天內
價格
Tauopathies治療市場 - COVID-19的影響分析,市場規模、佔有率、預測:2021年∼2027年 Tauopathies Treatment Market with COVID-19 Impact Analysis, By Disease, By Distribution Channel, and By Region - Size, Share, & Forecast from 2021-2027
出版日期: 2020年12月01日內容資訊: 英文 210 Pages
簡介

全球Tauopathies治療市場,2020年達到了7億2,930萬美元。市場,在2021年∼2027年的預測期間內,預計以9.8%的年複合成長率成長。

本報告提供全球Tauopathies治療市場相關調查分析,市場概要,市場動態,各市場區隔的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 Tauopathies治療市場概要

第2章 摘要整理

第3章 Tauopathies治療市場主要趨勢

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場未來趨勢

第4章 Tauopathies治療產業分析

  • 波特的五力分析
  • 行銷策略分析
  • 成長預測製圖
  • 法律規範分析

第5章 Tauopathies治療市場:COVID-19的影響分析

  • COVID-19前的影響分析
  • COVID-19後的影響分析

第6章 Tauopathies治療市場形勢

  • 市場佔有率分析
  • 主要創新者分析
  • 明細資料:各主要製造商

第7章 Tauopathies治療市場:各疾病

  • 概要
  • 腦前額顳葉退化症
  • 阿茲海默症
  • 其他神經退化性疾病

第8章 Tauopathies治療市場:各流通管道

  • 概要
  • 醫院藥局
  • 零售藥局
  • 線上

第9章 Tauopathies治療市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 主要供應商分析

  • 競爭儀表板
  • 企業簡介

第11章 分析師的見解

第12章 附錄

目錄

REPORT HIGHLIGHT

The global Tauopathies Treatment market was valued at USD 729.3 million in 2020, growing with 9.8% CAGR during the forecast period, 2021-2027.

Tauopathies are known as neurodegenerative disorders that are caused by abnormal deposition of tau protein in the brain. Major tauopathies disorders include corticobasal degeneration, Pick's disease, argyrophilic grain disease, and progressive supranuclear palsy. The tauopathies treatment market is estimated to witness significant growth in the next few years. The increasing number of patients affected by conditions such as progressive supranuclear palsy (PSP) and frontotemporal lobar degeneration (FTLD-TAU) corticobasal degeneration is projected to boost market growth. The tauopathies disorders are considered as age-related tauopathy including neurofibrillary tangle dementia, chronic traumatic encephalopathy (CTE), and aging-related tau astrogliopathy. Effective diagnosis is required in order to diagnose neurodegenerative disorders in patients, for which cost-effective screenings are recommended by physicians. Thus, the examination of the amygdala, hippocampus, and basal ganglia is widely preferred by the neurosurgeon.

The continuous focus on research & development by the companies to develop drugs for tauopathies treatment is expected to be a key factor for the market growth. Additionally, an increase in investments and rising health care spending by the government is also supporting market growth. Furthermore, the approvals of clinical trials are expected to proliferate the market growth and offer ample growth opportunities for the market players. For example, in 2017, Cortice Biosciences presented results from a placebo-controlled phase I double-blinded clinical study assessing 'TPI 287'. TPI 287 is a brain penetrable novel microtubule-stabilizing agent that is used for treating corticobasal syndrome (CBS), Alzheimer's disease (AD), and progressive supranuclear palsy (PSP).

North America is projected to dominate the market on account of the rising investment in therapy treatment. In 2020, Pfizer's asset of Parkinson's and Alzheimer's was acquired by Biogen for US$ 710 million. The company's aim behind this acquisition is to develop a CNS-penetrate inhibitor of CK1 for patients with neurological symptoms. Europe market estimated to be the second-largest market with high investment in tauopathies treatment development. On the other hand, Asia Pacific is also projected to expand at a significant rate over the forecast period.

The tauopathies treatment market is moderately competitive with the presence of international and local players. Key players such as Avanir Pharmaceuticals, Inc., Otsuka Pharmaceutical Co., Ltd., AB Science, and Cortice Biosciences holds the majority market share. Several players in the market engage in strategic mergers & acquisitions and new product developments to remain competitive in the industry.

Key features of the study:

This proposed research study on Tauopathies Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Tauopathies Treatment market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Tauopathies Treatment market

Impact of COVID-19 on Tauopathies Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Tauopathies Treatment market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Tauopathies Treatment market, we have also included competitive landscape and key innovator analysis for the Tauopathies Treatment market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Tauopathies Treatment market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Tauopathies Treatment market on global as well as regional level.

The global Tauopathies Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TAUOPATHIES TREATMENT MARKET KEY PLAYERS

Avanir Pharmaceuticals, Inc.

Cortice Biosciences

Otsuka Pharmaceutical Co., Ltd.

AB Science

REGENXBIO Inc.

Catalent Inc.

Aquinnah Pharmaceuticals

Neurimmune

Oligomerix, Inc.

Bristol-Myers Squibb Company

Biogen

TauRx,

Sellas,

Selvita S.A

Chronos Therapeutics Limited

GLOBAL TAUOPATHIES TREATMENT MARKET, BY DISEASE

Frontotemporal Degeneration

Corticobasal Degeneration (CBD)

Progressive Supranuclear Palsy (PSP)

Pick's Disease

Alzheimer's Disease

Other Neurodegenerative Diseases

GLOBAL TAUOPATHIES TREATMENT MARKET, BY DISTRIBUTRION CHANNEL

Hospital Pharmacy

Retail Pharmacy

Online

GLOBAL TAUOPATHIES TREATMENT MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Tauopathies Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Disease
    • 2.1.2. Market Snippet by Distribution Channel
    • 2.1.3. Market Snippet by Region
  • 2.2. Competitive Insights

3. Tauopathies Treatment Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Tauopathies Treatment Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tauopathies Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tauopathies Treatment Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Tauopathies Treatment Market - By Disease

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease, 2020 & 2027 (%)
  • 7.2. Frontotemporal Degeneration
    • 7.2.1. Corticobasal Degeneration (CBD)
    • 7.2.2. Progressive Supranuclear Palsy (PSP)
    • 7.2.3. Pick's Disease
  • 7.3. Alzheimer's Disease
  • 7.4. Other Neurodegenerative Diseases

8. Tauopathies Treatment Market - By Distribution Channel

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2020 & 2027 (%)
  • 8.2. Hospital Pharmacy
  • 8.3. Retail Pharmacy
  • 8.4. Online

9. Tauopathies Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.10. Rest of Europe
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.10.3. Rest of the Europe Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.3.10.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.10. Rest of APAC
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.10.3. Rest of APAC Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.4.10.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.9. Rest of LATAM
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.9.3. Rest of LATAM Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.5.9.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Disease, 2016 - 2027 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)

10. Key Vendor Analysis

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Avanir Pharmaceuticals, Inc.
    • 10.2.2. Cortice Biosciences
    • 10.2.3. Otsuka Pharmaceutical Co., Ltd.
    • 10.2.4. AB Science
    • 10.2.5. REGENXBIO Inc.
    • 10.2.6. Catalent Inc.
    • 10.2.7. Aquinnah Pharmaceuticals
    • 10.2.8. Neurimmune
    • 10.2.9. Oligomerix, Inc.
    • 10.2.10. Bristol-Myers Squibb Company
    • 10.2.11. Biogen
    • 10.2.12. TauRx,
    • 10.2.13. Sellas,
    • 10.2.14. Selvita S.A,
    • 10.2.15. Chronos Therapeutics Limited

11. 360 Degree AnalystView

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Tauopathies Treatment market: Diseases Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Diseases
  • TABLE Global Tauopathies Treatment market, by Diseases 2016-2027 (USD Million)
  • TABLE Tauopathies Treatment market: Application Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Tauopathies Treatment market, by Application 2016-2027 (USD Million)
  • TABLE Tauopathies Treatment market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Tauopathies Treatment market, by Region 2016-2027 (USD Million)
  • TABLE North America Tauopathies Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE North America Tauopathies Treatment market, by Diseases, 2016-2027 (USD Million)
  • TABLE North America Tauopathies Treatment market, by Application, 2016-2027 (USD Million)
  • TABLE Europe Tauopathies Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Tauopathies Treatment market, by Diseases, 2016-2027 (USD Million)
  • TABLE Europe Tauopathies Treatment market, by Application, 2016-2027 (USD Million)
  • TABLE Asia Pacific Tauopathies Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Tauopathies Treatment market, by Diseases, 2016-2027 (USD Million)
  • TABLE Asia Pacific Tauopathies Treatment market, by Application, 2016-2027 (USD Million)
  • TABLE Latin America Tauopathies Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Tauopathies Treatment market, by Disease, 2016-2027 (USD Million)
  • TABLE Latin America Tauopathies Treatment market, by Application, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Tauopathies Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Tauopathies Treatment market, by Disease, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Tauopathies Treatment market, by Application, 2016-2027 (USD Million)

List of Figures

  • FIGURE Tauopathies Treatment market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Disease segment market share analysis, 2020 & 2027
  • FIGURE Disease segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Application segment market share analysis, 2020 & 2027
  • FIGURE Application segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Tauopathies Treatment market share and leading players, 2019
  • FIGURE Europe Tauopathies Treatment market share and leading players, 2019
  • FIGURE Asia Pacific Tauopathies Treatment market share and leading players, 2019
  • FIGURE Latin America Tauopathies Treatment market share and leading players, 2019
  • FIGURE Middle East and Africa Tauopathies Treatment market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Tauopathies Treatment market share analysis by country, 2019
  • FIGURE Germany Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Tauopathies Treatment market share analysis by country, 2019
  • FIGURE India Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Tauopathies Treatment market share analysis by country, 2019
  • FIGURE Brazil Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Tauopathies Treatment market share analysis by country, 2019
  • FIGURE Saudi Arabia Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Tauopathies Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)